Fabian Sanchis Gomar-rekin lankidetzan egindako argitalpenak (12)

2017

  1. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: The WHOLEi + 12 trial

    International Journal of Cardiology, Vol. 231, pp. 277-283

  2. Circulating leptin and adiponectin concentrations in healthy exceptional longevity

    Mechanisms of Ageing and Development, Vol. 162, pp. 129-132

2016

  1. Biological rationale for regular physical exercise as an effective intervention for the prevention and treatment of depressive disorders

    Current Pharmaceutical Design, Vol. 22, Núm. 24, pp. 3764-3775

  2. Exercise as an adjuvant therapy against chronic atrial fibrillation

    International Journal of Cardiology, Vol. 207, pp. 180-184

  3. IPSCs-based anti-aging therapies: Recent discoveries and future challenges

    Ageing Research Reviews, Vol. 27, pp. 37-41

  4. Impact of gestational risk factors on maternal cardiovascular system

    Annals of Translational Medicine, Vol. 4, Núm. 13

  5. Maternal cardiac adaptations to a physical exercise program during pregnancy

    Medicine and Science in Sports and Exercise, Vol. 48, Núm. 5, pp. 896-906

  6. No evidence of adverse cardiac remodeling in former elite endurance athletes

    International Journal of Cardiology, Vol. 222, pp. 171-177

  7. Response rate to the treatment of Waldenström macroglobulinemia: A meta-analysis of the results of clinical trials

    Critical Reviews in Oncology/Hematology, Vol. 105, pp. 118-126

  8. ‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue

    Journal of Physiology, Vol. 594, Núm. 12, pp. 3187-3207

2015

  1. Predictive value of NT-proBNP combined with exercise capacity variables in pulmonary artery disease: Insights from a Spanish cohort

    International Journal of Cardiology, Vol. 186, pp. 32-34

  2. Rationale and Design of a Randomized Controlled Trial Evaluating Whole Muscle Exercise Training Effects in Outpatients with Pulmonary Arterial Hypertension (WHOLEi+12)

    Cardiovascular Drugs and Therapy, Vol. 29, Núm. 6, pp. 543-550